With LeadCare? II & HemoCue?, point-of-care testing solutions for lead & hemoglobin, physicians have the opportunity to test children’s blood levels within one office visit, counsel families during their visit, and help put parents’ minds at ease, one fingerstick at a time. HemoCue AB Click here to learn more: https://hubs.la/Q02Rn2_Q0
Meridian Bioscience Inc.的动态
最相关的动态
-
Vice President @ Teleflex | Product Management, Marketing, Integration and Business Development Leader
The power of data!
Teleflex is proud to sponsor two new head-to-head randomized controlled trials that compare the UroLift System to BPH medication and to Rezūm water vapor therapy (WVTT). See the early patient experience results. Be in the know: https://hubs.ly/Q02J4PzT0
-
-
Like any old friends, we’re better together. Find your exercise prescription streamlined through our seamless integration with Physitrack PLC. This dynamic duo is ready to help you wave goodbye to platform jumping and embrace a synchronised approach that helps you deliver the exceptional care your patients know and love. From automated data entry to unified therapeutic interventions, tailored programs with unparalleled precision have never been easier. So step into the future, where evidence-based care is just a click away. ?? Read more on The Handover: https://lnkd.in/gxVf7TZ4
-
-
Don't miss out! On December 5th, join Robin Sweeting and the Vigilance Santé team for an exclusive live demonstration of the powerful minor ailment integration: RxConsultAction in Propel Rx. During this session, you'll learn how to: ?? Enhance your professional services ?? Optimize your workflow ?? Eliminate manual paperwork Register today and take a step towards efficiency. https://lnkd.in/eZn9Rd8H #PharmacyTechnologySolutions #McKessonCanada #PropelRx
-
-
Innovation | Transformation | Author| Systems Leadership | Systems-psychodynamic OD | ISPSO
The evidence is compelling and unrelenting, and as I enter my third decade facing these appalling statistics, the urgency for change is clearer than ever. These statistics aren't just numbers—they reflect a serious risk to patients. It's time for improved PIVC insertion and good practices to become the norm.?? The most frequently performed invasive procedure in healthcare—peripheral intravenous catheter (PIVC) insertion—continues to have alarmingly high failure rates. 1. Helm et al. found that 60%-90% of hospitalised patients in the U.S. require a PIVC during their care, with failure rates ranging from 35%-50%. 2. Cooke et al. reported even higher global rates, with 33%-69% of PIVCs failing before treatment completion. 3. Practice variability leads to a range of complications such as infiltration, infection, and discomfort, with Zingg et al. corroborating a global failure rate of 35%-50%. 4. The Australian Commission on Safety and Quality in Health Care highlights complication rates as high as 70%. 5. A systematic review by Marsh et al. echoed this, noting that at least one-third of PIVCs inserted globally fail before completing the intended therapy. Thank you to all contributors including: Blake Hotchkiss MSN, MBA, RN, VA-BC Nicole Marsh Judy Thompson #QualityCare
We are delighted to announce the publication of "Standards of Care for Peripheral Intravenous Catheters: Evidence-Based Expert Consensus." This valuable resource is now available as open access, and you are invited to download a copy at your convenience. Please visit https://loom.ly/Nkc8Qzg to access the document and stay informed about the latest guidelines and expert opinions in the field of peripheral intravenous care.
-
-
Exciting news. New England Life Care (NELC) has chosen Inovalon's ScriptMed? to optimize its home infusion therapy operations. This partnership will help deliver patient-centered care with greater efficiency and impact. Thrilled to see how ScriptMed is shaping the future of home infusion. https://ow.ly/2W4B30sJfVR
-
-
"Of all the advancements in PE #thrombectomy, the FlowSaver is the biggest." Drs. Ripal Gandhi, M.D., FSVM, FSIR and Andrew Niekamp discuss how the #FlowSaver Blood Return System allows interventionalists to focus on clinically meaningful endpoints and treat patients more effectively. Learn more about FlowSaver, celebrating use with 70k+ patients. #SIR #FlowTriever
-
Excellent talk all interventionalists should l watch
"Of all the advancements in PE #thrombectomy, the FlowSaver is the biggest." Drs. Ripal Gandhi, M.D., FSVM, FSIR and Andrew Niekamp discuss how the #FlowSaver Blood Return System allows interventionalists to focus on clinically meaningful endpoints and treat patients more effectively. Learn more about FlowSaver, celebrating use with 70k+ patients. #SIR #FlowTriever
-
Don't miss out! On November 13th, join Robin Sweeting and the Vigilance Santé team for an exclusive live demonstration of the powerful minor ailment integration: RxConsultAction in Propel Rx. During this session, you'll learn how to: ?? Enhance your professional services ?? Optimize your workflow ?? Eliminate manual paperwork Register today and take the first step towards efficiency. https://ow.ly/eh4x50U4C7u #PharmacyTechnologySolutions #McKessonCanada #PropelRx
-
-
The #ZoomStrokeSolution is the first purpose-built, comprehensive #stroke system from access through clot capture designed to allow physicians to treat patients based on their specific needs with speed and efficiency. Connect with your local rep to learn more about our recent FDA clearance of the #ZoomSystem, and Imperative Trial results underscoring the clinical benefits of Zoom: https://lnkd.in/dkQyUqSF #Zoom88 #IntracranialAccess #ZoomPOD #ElevatingStrokeCare Rx only. ISI: https://bit.ly/3yWkfEJ
-
Site performance issues? Consult with our site Luminaries to get insights on improving operational efficiency and patient retention at your trial sites. Deena Bernstein, Carlos E. Orantes, Nicholas Focil, Jimmy Bechtel, MBA, Brad Hightower, Micah Lieberman #ClinicalSites #ResearchEfficiency #ClinicalTrials *Only registered members can ask questions. Not registered yet? Join the ClinEco community today - it's free and simple!
